Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Topcon and Orbis Partner to Expand DR Screening in Rwanda
Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…
Okyo Pharma’s Phase 2 Trial for Neuropathic Corneal Pain
Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of neuropathic corneal pain (NCP), scheduled to begin in the third quarter of 2024. This one-year study follows promising results from preclinical animal…
ENTOD Pharma Introduces New Eye Drop Preservative System
Mumbai-based ENTOD Pharmaceuticals has unveiled a novel advancement in ophthalmic care with the introduction of EyeBS, a new eye drop preservative system. EyeBS is specifically designed to supplant traditional detergent-based preservatives such as Benzalkonium Chloride (BAK) and Polyquaternium-1, offering a…
Researchers Discover New Imaging Technique for MS Diagnosis
Researchers from Durham University, UK, and Isfahan University of Medical Sciences, Iran, have discovered a pioneering method for diagnosing multiple sclerosis (MS) using advanced eye imaging techniques. Published in the journal Translational Vision Science & Technology, their work introduces a…
Ophthalmologic Manifestations of Acute Leukemia Are Detectable
Acute leukemia can present with various ophthalmologic manifestations, which are detectable at both initial presentation and relapse, according to a study published online on July 10 in the Annals of Hematology. Dr. Dina N. Laimon and her colleagues from Mansoura…
FDA Clears Enhanced SPECTRALIS® OCTA Module by Heidelberg
Heidelberg Engineering announced the FDA clearance of its upgraded SPECTRALIS® OCTA Module featuring SHIFT technology. This advancement promises to significantly reduce acquisition time by 50%, marking a pivotal development in clinical efficiency and diagnostic precision within ophthalmology. Enhancing Clinical Utility…
Sydnexis Appoints Perry J. Sternberg as CEO
Sydnexis, Inc., a pioneering biopharmaceutical company dedicated to addressing pediatric myopia progression, has appointed Perry J. Sternberg as its Chief Executive Officer and as a member of its Board of Directors. Sternberg, a seasoned pharmaceutical and biotech executive with over…
Glaukos Activates CMS J-Code for iDose TR
Glaukos Corporation has confirmed the activation of the CMS Healthcare Common Procedure Coding System’s J-code—J7355—for its iDose TR product. This development marks a significant milestone in enhancing patient access and streamlining coverage and payment processes for the innovative treatment, according…
Rethinking Antibiotic Use in Pediatric Pink Eye Cases
In a recent study published in the journal JAMA Ophthalmology, researchers revealed troubling trends in the treatment of pink eye among children and teens in the United States. Despite guidelines from the American Academy of Ophthalmology discouraging the use of…
Beacon Therapeutics Propels Gene Therapy with $170M Funding
Beacon Therapeutics has successfully raised $170 million in Series B funding, marking a significant step forward in advancing its portfolio of ophthalmic gene therapies. The funds are earmarked to support the ongoing clinical development of Beacon’s lead candidate, AGTC-501, designed…